BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND RAC1, ENSG00000136238, 5879, MIG5, MGC111543, P63000, p21-Rac1, TC-25 AND Prognosis
22 results:

  • 1. Mucin 5AC-Mediated CD44/ITGB1 Clustering Mobilizes Adipose-Derived Mesenchymal Stem Cells to Modulate Pancreatic cancer Stromal Heterogeneity.
    Ganguly K; Cox JL; Ghersi D; Grandgenett PM; Hollingsworth MA; Jain M; Kumar S; Batra SK
    Gastroenterology; 2022 Jun; 162(7):2032-2046.e12. PubMed ID: 35219699
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The R-enantiomer of ketorolac reduces ovarian cancer tumor burden in vivo.
    Grimes MM; Kenney SR; Dominguez DR; Brayer KJ; Guo Y; Wandinger-Ness A; Hudson LG
    BMC Cancer; 2021 Jan; 21(1):40. PubMed ID: 33413202
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Macrophage-mediated vascular permeability via VLA4/VCAM1 pathway dictates ascites development in ovarian cancer.
    Zhang S; Xie B; Wang L; Yang H; Zhang H; Chen Y; Wang F; Liu C; He H
    J Clin Invest; 2021 Feb; 131(3):. PubMed ID: 33295887
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Elevated TIAM2 expression promotes tumor progression and is associated with unfavorable prognosis in pancreatic cancer.
    Jiang B; Zhou L; Lu J; Wang Y; Liu C; Zhou W; Guo J
    Scand J Gastroenterol; 2021 Jan; 56(1):59-67. PubMed ID: 33284659
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Pattern of Invasion in Human Pancreatic cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome.
    Huang W; Navarro-Serer B; Jeong YJ; Chianchiano P; Xia L; Luchini C; Veronese N; Dowiak C; Ng T; Trujillo MA; Huang B; Pflüger MJ; Macgregor-Das AM; Lionheart G; Jones D; Fujikura K; Nguyen-Ngoc KV; Neumann NM; Groot VP; Hasanain A; van Oosten AF; Fischer SE; Gallinger S; Singhi AD; Zureikat AH; Brand RE; Gaida MM; Heinrich S; Burkhart RA; He J; Wolfgang CL; Goggins MG; Thompson ED; Roberts NJ; Ewald AJ; Wood LD
    Cancer Res; 2020 Jul; 80(13):2804-2817. PubMed ID: 32376602
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Role of Dimerized C16orf74 in Aggressive Pancreatic cancer: A Novel Therapeutic Target.
    Kushibiki T; Nakamura T; Tsuda M; Tsuchikawa T; Hontani K; Inoko K; Takahashi M; Asano T; Okamura K; Murakami S; Kurashima Y; Ebihara Y; Noji T; Nakanishi Y; Tanaka K; Maishi N; Sasaki K; Park WR; Shichinohe T; Hida K; Tanaka S; Hirano S
    Mol Cancer Ther; 2020 Jan; 19(1):187-198. PubMed ID: 31597713
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. KRAS G12V Mutation in Acquired Resistance to Combined BRAF and MEK Inhibition in Papillary Thyroid cancer.
    Owen DH; Konda B; Sipos J; Liu T; Webb A; Ringel MD; Timmers CD; Shah MH
    J Natl Compr Canc Netw; 2019 May; 17(5):409-413. PubMed ID: 31085763
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Inhibition of fascin in cancer and stromal cells blocks ovarian cancer metastasis.
    McGuire S; Kara B; Hart PC; Montag A; Wroblewski K; Fazal S; Huang XY; Lengyel E; Kenny HA
    Gynecol Oncol; 2019 May; 153(2):405-415. PubMed ID: 30797592
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Regulation of extracellular matrix degradation and metastatic spread by IQGAP1 through endothelin-1 receptor signalling in ovarian cancer.
    Chellini L; Caprara V; Spadaro F; Sestito R; Bagnato A; Rosanò L
    Matrix Biol; 2019 Aug; 81():17-33. PubMed ID: 30367951
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. ARHGEF4 predicts poor prognosis and promotes cell invasion by influencing ERK1/2 and GSK-3α/β signaling in pancreatic cancer.
    Taniuchi K; Furihata M; Naganuma S; Saibara T
    Int J Oncol; 2018 Nov; 53(5):2224-2240. PubMed ID: 30226582
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. MicroRNA 483-3p targets Pard3 to potentiate TGF-β1-induced cell migration, invasion, and epithelial-mesenchymal transition in anaplastic thyroid cancer cells.
    Zhang X; Liu L; Deng X; Li D; Cai H; Ma Y; Jia C; Wu B; Fan Y; Lv Z
    Oncogene; 2019 Jan; 38(5):699-715. PubMed ID: 30171257
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Integrated analysis of tumor differentiation genes in pancreatic adenocarcinoma.
    Xi T; Zhang G
    PLoS One; 2018; 13(3):e0193427. PubMed ID: 29596435
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Cross-linked hyaluronan gel inhibits the growth and metastasis of ovarian carcinoma.
    Pang J; Jiang P; Wang Y; Jiang L; Qian H; Tao Y; Shi R; Gao J; Chen Y; Wu Y
    J Ovarian Res; 2018 Mar; 11(1):22. PubMed ID: 29510732
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Pro-migratory and TGF-β-activating functions of αvβ6 integrin in pancreatic cancer are differentially regulated via an Eps8-dependent GTPase switch.
    Tod J; Hanley CJ; Morgan MR; Rucka M; Mellows T; Lopez MA; Kiely P; Moutasim KA; Frampton SJ; Sabnis D; Fine DR; Johnson C; Marshall JF; Scita G; Jenei V; Thomas GJ
    J Pathol; 2017 Sep; 243(1):37-50. PubMed ID: 28608476
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Vav3 is linked to poor prognosis of pancreatic cancers and promotes the motility and invasiveness of pancreatic cancer cells.
    Tsuboi M; Taniuchi K; Furihata M; Naganuma S; Kimura M; Watanabe R; Shimizu T; Saito M; Dabanaka K; Hanazaki K; Saibara T
    Pancreatology; 2016; 16(5):905-16. PubMed ID: 27453460
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. ARHGEF15 overexpression worsens the prognosis in patients with pancreatic ductal adenocarcinoma through enhancing the motility and proliferative activity of the cancer cells.
    Fukushima H; Yasumoto M; Ogasawara S; Akiba J; Kitasato Y; Nakayama M; Naito Y; Ishida Y; Okabe Y; Yasunaga M; Horiuchi H; Sakamoto E; Itadani H; Mizuarai S; Oie S; Yano H
    Mol Cancer; 2016 May; 15(1):32. PubMed ID: 27145964
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. rac1 expression in epithelial ovarian cancer: effect on cell EMT and clinical outcome.
    Leng R; Liao G; Wang H; Kuang J; Tang L
    Med Oncol; 2015 Feb; 32(2):329. PubMed ID: 25585684
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Novel therapeutic targets for pancreatic cancer.
    Tang SC; Chen YC
    World J Gastroenterol; 2014 Aug; 20(31):10825-44. PubMed ID: 25152585
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. FZD7 drives in vitro aggressiveness in Stem-A subtype of ovarian cancer via regulation of non-canonical Wnt/PCP pathway.
    Asad M; Wong MK; Tan TZ; Choolani M; Low J; Mori S; Virshup D; Thiery JP; Huang RY
    Cell Death Dis; 2014 Jul; 5(7):e1346. PubMed ID: 25032869
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. rac1b overexpression in papillary thyroid carcinoma: a role to unravel.
    Silva AL; Carmo F; Bugalho MJ
    Eur J Endocrinol; 2013 Jun; 168(6):795-804. PubMed ID: 23482591
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.